Viewing nowAlphedrine 25 mg Tablets (Orphenadrine Hydrochloride)
Orphenadrine Hydrochloride 25mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.

MFDS item code 199701555 · Notified 1997.03.31 · Insurance code 653701100
Treatment of parkinsonism (e.g., idiopathic or postencephalitic); relief of pain from skeletal muscle spasms
This medication is used for idiopathic Parkinson's disease and other types of Parkinson's disease occurring after encephalitis or atherosclerosis. It is also effective for relieving pain caused by skeletal muscle spasms. Therefore, it helps improve motor function disorders associated with Parkinson's disease and reduce discomfort caused by muscle cramps.
(Oral: tablets) Adults: Administer 50㎎ of olpadrine hydrochloride orally 3 times daily. Adjust the dose appropriately according to age and symptoms. (Injection) Adults: Administer 80-120㎎ (4-6㎖) of olpadrine hydrochloride daily by intramuscular injection. Adjust the dose appropriately according to age and symptoms.
This medication should not be used in patients with glaucoma. Patients with obstruction of the pylorus or duodenum should also not take this medication. It should not be administered to patients with obstructive peptic ulcers. Those with benign prostatic hyperplasia or bladder neck obstruction should also avoid this medication. This medication is not suitable for patients with esophageal motility disorders such as esophageal spasm or achalasia. Patients with myasthenia gravis should refrain from using this medication. Individuals with an allergic reaction to this medication should not use it. Additionally, since this medication contains lactose, patients with lactose intolerance or certain genetic metabolic disorders should not take it. Patients with tachycardia or cardiovascular diseases should exercise caution when using this medication. Patients with liver or kidney dysfunction should also use this medication with care. Taking this medication may cause symptoms such as dry mouth, palpitations, constipation, urinary difficulties, blurred vision, nausea, vomiting, drowsiness, headaches, dizziness, and skin rashes. Most of these symptoms will resolve by reducing the dosage or discontinuing the medication. This medication can lead to drug dependence, so it should not be abruptly discontinued; instead, it should be gradually reduced under the guidance of a physician. For pregnant or breastfeeding women, the safety of this medication has not been sufficiently established, so it should only be used after consulting a physician, and only when necessary. In the case of children or infants, safety has also not been established, so it should be used cautiously and only when necessary.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a tightly sealed container that blocks light. Additionally, it is best to avoid extremely hot or cold environments and store the medication at room temperature, between 1 to 30 degrees Celsius.
Light yellow round tablet
500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOrphenadrine Hydrochloride 25mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.

Orphenadrine Hydrochloride 25mg
Tablet · Prescription medication
Yuyoung Pharmaceutical Co., Ltd.

Orphenadrine Hydrochloride 25mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.